CIRCULATORY HSA-MIR-339-5P IS ASSOCIATED WITH LATER DEVELOPMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE IN THE PROSPECTIVE YOUNG FINNS STUDY

Daria Kostiniuk  ¹     Linnea Aitokari  ²     Olli Raitakari  ^{3, 4}     Mika Kähönen  ⁵     Terho Lehtimäki  ⁶     Kalle Kurppa  ^{2, 7}     Emma Raitoharju  ^{1, 6    
1} Molecular Epidemiology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
² Tampere Center for Child, Adolescent and Maternal Health Research and Celiac Disease Research Center, Tampere University, Tampere, Finland
³ Research Centre for Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland
⁴ University of Turku and Turku University Hospital, Turku, Finland
⁵ Tampere University and Tampere University Hospital, Tampere, Finland
⁶ Tampere University, Tampere, Finland
⁷ The University Consortium of Seinäjoki, Seinäjoki, Finland

Topic
Hepatobiliary

Session
Progress in liver disease biomarkers

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)